Company: EVGN
Filing Date: 2025-09-30
Form Type: POS AM
Source: 0001178913-25-003429
Chunk: 11

Company: Evogene Ltd.
Filing Date: 2025-09-30
Form: POS AM
Chunk 11
---
 not be eligible for any compliance period and the Listing Qualifications Department will issue a Delisting Determination under Rule 5810 with respect to that company’s securities. This change will apply to a company even if the company was in compliance with the bid price requirement at the time of its prior reverse share split. In addition, if a company’s security fails to meet the bid price requirement and the company has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, referred to as the Maximum Cumulative Ratio, then the company is not eligible for any compliance periods and Nasdaq must issue a Delisting Determination with respect to that security. While one year has already passed since our Reverse Split, we will still be limited in effecting any additional reverse share splits prior to the passage of two years since the Reverse Split (i.e., until July 24, 2026) to the extent the cumulative effect of the Reverse Split and any such future reverse splits would exceed the Maximum Cumulative Ratio. Consequently, if our ordinary shares trade below $1.00 per share for 30 consecutive business days and we would need to effect a reverse share split to raise our share price above $1.00, and such a reverse share split would cause us to exceed the Maximum Cumulative Ratio, we could be ineligible for any compliance period and the Listing Qualifications Department would issue a Delisting Determination for our ordinary shares. In the event that our ordinary shares are delisted from Nasdaq due to our failure to continue to comply with the requirements for continued listing on Nasdaq, and are not eligible for listing on another national securities exchange, and trading in our ordinary shares and warrants could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our ordinary shares and warrants, and it would likely be more difficult to obtain coverage by securities analysts and the news media, which could cause the price of our ordinary shares to decline further. Also, it may be difficult for us to raise additional capital if we are not listed on a national exchange, and we could suffer reputational damage and diminished investor, supplier, and employee confidence. Finally, if the volatility in the broader capital markets increases, that could have an adverse effect on the market price of our ordinary shares, regardless of our operating performance. 7